| Project/Area Number |
11470157
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Circulatory organs internal medicine
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
OUCHI Yasuyoshi Department of Geriatric Medicine, The University of Tokyo, Professor, 医学部・附属病院, 教授 (80168864)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KOZAKI Koichi Department of Geriatric Medicine, The University of Tokyo, Assistant, 医学部・附属病院, 助手 (80272540)
INOUE Satoshi Department of Geriatric Medicine, The University of Tokyo, Senior Assistant, 医学部・附属病院, 講師 (40251251)
YOSHIZUMI Masao Department of Geriatric Medicine, The University of Tokyo, Senior Assistant, 医学部・附属病院, 講師 (20282626)
IIJIMA Katsuya Department of Geriatric Medicine, The University of Tokyo, Assistant, 医学部・附属病院, 助手 (00334384)
阿古 潤哉 東京大学, 医学部・附属病院, 講師 (60292744)
秋下 雅弘 杏林大学, 医学部・附属病院, 講師 (00261975)
|
|---|
| Project Period (FY) |
1999 – 2001
|
| Project Status |
Completed (Fiscal Year 2001)
|
| Budget Amount *help |
¥11,800,000 (Direct Cost: ¥11,800,000)
Fiscal Year 2001: ¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 2000: ¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 1999: ¥4,900,000 (Direct Cost: ¥4,900,000)
|
|---|
| Keywords | estrogen receptor / vascular smooth muscle cells / adeno virus vector / DNA chip / 血管平滑筋細胞 / DNA chip / 内皮細胞 / 平滑筋細胞 / 増殖 / アポトーシス |
|---|
| Research Abstract |
The goal of our study is to elucidate the atheroprotective effects of estrogen, especially the role of estrogen receptor (ER) subtype, and to apply a new therapeutic method using ER to prevent atherosclerosis. We have gained six results for the three years, described below. (1) We examined the influence of diabetes mellitus on atherosclerosis in relation to ER. We showed that the expression of Erα was decreased in high glucose state in cultured vascular smooth muscle cells, mediated through the activation of protein kinase C. (2) We successfully constructed transgenic mouse overexpressing mutant ER which has a dominant negative transcriptional activity to both Erα and Erβ. Neointima was formed in this mouse by placing polyethylene cuff around the femoral artery. By this method, we were able to clarify the biophysical effect of ER. (3) We examined which ER subtype was involved in the inhibitory effect of estrogen on vascular smooth muscle cell proliferation using adenovirus-mediated overexpression of Erα and β. We found that the inhibitory effect was mediated mainly via Erβ. (4) Apoptosis of vascular endothelium is supposed to be related to the initiation of atherosclerotic lesion. We showed that estrogen attenuated apoptosis of endothelium. This effect was mediated, in part, through the downregulation of Bax expression. (5) Obesity is one of the important risk factors for atherosclerosis, and estrogen has anti-obese effect. We found that the mechanism of the inhibitory effect of estrogen is through Erβ expressed in the central nervous system. (6) We investigated the association between the polymorphism of CA (cytosine-adenine) repeat in the upstream of Erβ gene and blood pressure in 187 Japanese postmenopausal women. We found that a group of subjects who bears a specific CA repeats showed significant systolic hypertension.
|
